Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia
FD is a rare neurodegenerative disorder caused by a mutation of the IKBKAP gene, which induces low expression levels of the Elongator subunit IKAP/hELP1 protein. A rational strategy for FD treatment could be to identify drugs increasing IKAP/hELP1 expression levels by blocking protein degradation pa...
Main Authors: | Mylène Hervé, El Chérif Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996117300839 |
Similar Items
-
IKBKAP/ELP1 gene mutations: mechanisms of familial dysautonomia and gene-targeting therapies
by: Rubin BY, et al.
Published: (2017-12-01) -
Familial Dysautonomia: Mechanisms and Models
by: Paula Dietrich, et al. -
Familial Dysautonomia: Mechanisms and Models
by: Paula Dietrich, et al. -
MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia
by: Mylène Hervé, et al.
Published: (2016-08-01) -
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
by: Diego Acosta-Alvear, et al.
Published: (2015-09-01)